CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Material agreement · Agreement ended · New debt or obligation
- 8-K Event Material agreement · Unregistered share sale · Other events
- DEF 14A Proxy Proxy Statement
- 8-K Event Shareholder vote results
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K/A Event Exhibits
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- 8-K/A Event Auditor change
- 8-K Event Executive or director change
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Auditor change · Bylaws or fiscal year change · Other events
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Executive or director change
- 8-K/A Event Acquisition or sale completed · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shareholder vote results · Other events
Page 8 of 18 · 360 filings